FDA 483 - SI Group, Inc. - January 15, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
SI Group, Inc. in Orangeburg, SC, an Active Pharmaceutical Ingredient manufacturer, was cited for three observations during an FDA inspection. The inspection revealed deficiencies in the calibration and verification of scales used in Propofol API packaging operations, a lack of proper second verification for packaged API weight, and uncertified areas within the packaging cleanroom. These issues indicate potential concerns with quality control and environmental monitoring in their manufacturing processes.
ID · d852b16d-73ec-4972-964d-7af3362c1901